Questcor Sees No Adverse Effect From Aetna Payment Change

Questcor Pharmaceuticals Inc., which sank the most in 20 years yesterday after insurer Aetna Inc. said it would limit coverage of the company’s top-selling drug, is in discussions with the insurer and doesn’t expect the decision to hurt business, executives told investors.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.